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BACKGROUND 
The writing of prescriptions is an important aspect of 
medical practice. This activity presents some particular 
problems given the risk of interpretation and dispensing 
errors in community pharmacies. Since 2006, the Swiss 
authorities have decided to impose incentives to prescribe 
generic drugs. 
 
OBJECTIVES 
• To determine the evolution of the outpatient prescription 
practice in our paediatric university hospital during 2 
periods separated by 5 years. 
• To assess the writing quality of outpatient prescriptions 
during the same periods. 
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CONCLUSION  
 
• This study showed that physicians' prescriptions comprised numerous omissions and errors with minimal potential 
 for harm.  
• No improvement was noticed during the 2 study periods. On the contrary, more errors were detected in 2010, mainly 
 because of drugs out of the market and wrong drug names.  
• Eighty percent of the lines of prescriptions had one (or more) of the 15 most frequently prescribed drugs.  
• A higher proportion of drugs were prescribed as generic names or generics in 2010 (25.2% vs 20.6% in 2005). 
• Computerized prescription coupled with advanced decision support is eagerly awaited. 
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SETTING   
Paediatric general hospital attached to a university hospital. 
METHODS 
Copies of prescriptions written by physicians were collected twice from 
community pharmacies in the region of the HEL for a two-month period in 
2005 and 2010. They were analysed according to standard criteria 
regarding both formal and pharmaceutical aspects [1, 2].  
Drug prescriptions were classified as:  
a) complete when all criteria for safety were fulfilled, 
b) ambiguous when there was a danger of a dispensing error because of 
one or more criteria missing, or  
c) containing an error.  
Comparisons between frequencies were achieved using the Fisher's 
exact test. 
RESULTS 
Table 1 : Analysed prescriptions Table 2 : The 15 most prescribed drugs Fig. 1 : Formal criteria regarding  
the prescribers 
Fig. 3 : Formal criteria regarding 
the drugs  
Table 3 : Prescribing problems and errors 
2005 2010 
Rank Drugs n (%) Drugs n (%) 
1 Paracetamol (acetaminophen) 370 (23.6) Paracetamol (acetaminophen) 333 (22.8) 
2 Ibuprofen 246 (15.7) Ibuprofen 317 (21.7) 
3 Sodium choride 168 (10.7) Sodium choride 130 (8.9) 
4 Chlorhexidine - oxybuprocaine 70 (4.5) Amoxicillin 99 (6.8) 
5 Amoxicillin 63 (4.0) Oral rehydration solution 53 (3.6) 
6 Oxomemazine - guaifenesin -  46 (2.9) Oxymetazoline 49 (3.4) 
sodium benzoate  
7 Amoxicillin - clavulanic acid 37 (2.4) Salbutamol (albuterol) 42 (2.9) 
8 Salbutamol (albuterol) 36 (2.3) Amoxicillin - clavulanic acid 26 (1.8) 
9 Mefenamic acid 34 (2.2) Dimethindene 23 (1.6) 
10 Xylometazoline 33 (2.1) Phenoxymethylpenicillin 23 (1.6) 
11 Codeine - phenyltoloxamine  33 (2.1) Chamomile extract 18 (1.2) 
12 Phenylephrine (nasal)  30 (1.9) Polymyxin B - Neomycin 17 (1.2) 
13 Oxymetazoline 28 (1.8) Mefenamic acid 17 (1.2) 
14 Xylometazoline -carbocisteine 24 (1.5) Xylometazoline 15 (1.0) 
15 Phenoxymethylpenicillin 23 (1.5) Dexpanthenol 13 (0.9) 
Total  1241 (79.0) 1175 (80.4) 
Fig. 2 : Formal criteria regarding 
the patients 
2005 2010  
Criteria  n (%) n (%) p 
Patient's name readable with difficulty or unreadable  1 65 (10.0) 74 (10.7) 0.72 
Drug prescription readable with difficulty   2 51 (3.2) 78 (5.3) 0.0051 
Incomplete drug prescription 3 664 (48.5) 797 (64.2) < 0.0001 
Ambiguous drug prescription 3 155 (11.3) 193 (15.5) 0.0018 
Drug prescriptions containing an error, 2 47 (3.0) 108 (7.4) < 0.0001 
 Illegible drug name  0 1 
 Drug out of the market 4 21 
 Wrong name 0 25 
 Wrong pharmaceutical form 9 9 
 Wrong strength / concentration 15 13 
 Wrong dose or frequency of administration 7 14 
 Wrong quantity / nb of packages 4 12 25  
1   n = 651 (2005) and 693 (2010) 
2   n = 1570 (2005) and 1462 (2010) 
3   n = 1370 (2005) and 1242 (2010) 
4  Treatment duration  present on the   prescriptions 
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  2005 2010 
Prescriptions, n 651 693 
    Outpatient clinics, n (%) 597 (91.7) 633 (91.3) 
    Hospitalisation, n (%) 54 (8.3) 60 (8.6) 
Lines of drug prescriptions, n 1570 1462 
    Detailed drug prescriptions, n (%) 1370 (87.3) 1242 (85.0) 
    Prescriptions with just the drug name, n (%) 200 (12.7) 220 (15.0) 
Drugs, mean ± SD 2.4 ± 1.2 2.1 ± 1.1 
Generic drugs or generic names, n (%) 324 (20.6) 369 (25.2) 
Patients' age, mean ± SD 5.4 ± 4.5 6.1 ± 4.7 
      
